Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions
Diabetes MellitusHypertension
Interventions
DRUG

Fimasartan

16 weeks of fimasartan vs. amlodipine followed by 2 weeks of wash-out period, then crossover

DRUG

Amlodipine

16 weeks of fimasartan vs. amlodipine followed by 2 weeks of wash-out period, then crossover

Trial Locations (1)

110-144

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02312375 - Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter